What pension research reveals about retirement planning

As the cost of living crisis eases, what steps are you taking to build your pension?

Viking Therapeutics, Inc. (VKTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Add to watchlist

67.51

+0.51

(+0.77%)

At close: 04:00PM EDT

68.00

+0.49

(+0.72%)

Pre-market:

07:00AM EDT

Loading interactive chart…

Zacks
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli Lilly's, Viking, Altimmune, Roche and Amgen
Novo Nordisk, Eli Lilly's, Viking, Altimmune, Roche and Amgen are included in this Analyst Blog.
Zacks
4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly
Though obesity drugs continue to gain traction, it is currently a duopoly market. As analysts expect demand to grow at an encouraging pace, several biotech/pharma companies are rushing to enter this space.
Zacks
Should You Hold Viking Therapeutics (VKTX) in Your Portfolio?
Viking Therapeutics' (VKTX) lead candidate for obesity, VK2735, is expected to have tremendous potential. However, existing competition from obesity drugs in the market remains a woe.